Skip to main content
Image coming soon

Board-Level AI in Pharmaceutical R&D Operations for Regulated Industries

$199.00
Adding to cart… The item has been added

A tailored course, built for your situation

Board-Level AI in Pharmaceutical R&D Operations for Regulated Industries

A 12-module implementation-grade course for advancing AI governance and operational strategy in drug development

$199 one-time
24-hour access provisioning 30-day money-back guarantee Hand-built implementation playbook
12 modules. 12 chapters per module. 144 chapters total.
12 modules, each with 12 chapters (144 chapters total), text-based, plus downloadable templates and a hand-built implementation playbook delivered alongside course access.
Navigating AI adoption in pharmaceutical R&D without clear governance can delay approvals, increase compliance risk, and limit board support.

The situation this course is for

As AI tools enter core R&D workflows, teams face growing pressure to demonstrate control, reproducibility, and regulatory alignment, yet most lack structured frameworks to present progress, risks, and ROI to executive stakeholders.

Who this is for

Business and technology leaders in pharmaceutical or life sciences organizations driving AI adoption in R&D under FDA, EMA, or other regulatory frameworks.

Who this is not for

This course is not for software developers seeking coding tutorials or data scientists focused on model architecture alone.

What you walk away with

  • Articulate a board-ready AI strategy aligned with R&D objectives and regulatory requirements
  • Implement governance frameworks that satisfy audit and compliance expectations
  • Orchestrate cross-functional AI initiatives spanning research, clinical, and regulatory teams
  • Leverage AI to accelerate trial design, compound selection, and safety profiling with documented control
  • Communicate AI progress, risks, and value clearly to non-technical executives and oversight bodies

The 12 modules (with all 144 chapters)

Module 1. AI at the Board Level: Strategic Oversight in Pharma
Establish the executive context for AI in drug development and define leadership expectations.
12 chapters in this module
  1. Defining board-level AI engagement in life sciences
  2. Mapping AI initiatives to strategic R&D goals
  3. Key governance expectations from directors and investors
  4. Balancing innovation speed with regulatory prudence
  5. Setting measurable outcomes for AI-driven R&D
  6. Aligning AI vision with corporate risk appetite
  7. Integrating AI updates into board reporting cycles
  8. Building board literacy on AI capabilities and limits
  9. Case study: AI strategy approval in a global pharma
  10. Common pitfalls in executive AI communication
  11. Creating a shared language between technical and non-technical leaders
  12. From approval to accountability: sustaining board engagement
Module 2. Regulatory Frameworks for AI in Drug Development
Navigate FDA, EMA, and ICH guidelines as they apply to AI-augmented R&D processes.
12 chapters in this module
  1. Understanding AI classification under current regulatory pathways
  2. Interpreting GLP, GCP, and GMP implications for AI systems
  3. Regulatory expectations for data provenance and model traceability
  4. Preparing for AI-related inspection readiness
  5. Documentation standards for algorithmic decision support
  6. Handling model updates and version control in regulated settings
  7. Aligning with ICH M10 and other emerging AI-relevant guidance
  8. Engaging regulators proactively on AI use cases
  9. Establishing audit trails for AI-assisted analyses
  10. Managing third-party AI vendor compliance
  11. Cross-jurisdictional considerations for global trials
  12. Building a regulatory intelligence function for AI
Module 3. AI Governance: Structure, Roles, and Accountability
Design a governance model that ensures oversight, transparency, and cross-functional alignment.
12 chapters in this module
  1. Defining the AI governance committee in pharma
  2. Assigning roles: sponsor, steward, validator, reviewer
  3. Establishing escalation paths for model risk issues
  4. Integrating AI governance with existing quality systems
  5. Creating stage-gate reviews for AI project lifecycle
  6. Documenting governance decisions and rationale
  7. Ensuring independence in model validation processes
  8. Managing conflicts between innovation and control teams
  9. Linking governance to performance metrics
  10. Training governance participants on AI fundamentals
  11. Scaling governance across multiple therapeutic areas
  12. Evaluating governance maturity over time
Module 4. Risk Management for AI in Regulated R&D
Apply structured risk assessment to AI systems across discovery, preclinical, and clinical phases.
12 chapters in this module
  1. Identifying AI-specific risks in drug development
  2. Using failure mode and effects analysis (FMEA) for AI
  3. Assessing bias, drift, and overfitting in biological datasets
  4. Quantifying impact on patient safety and trial integrity
  5. Developing risk mitigation playbooks for high-severity scenarios
  6. Implementing risk-based testing protocols
  7. Monitoring model performance in production environments
  8. Establishing thresholds for model retraining or retirement
  9. Linking risk assessments to change control processes
  10. Reporting risk exposure to compliance and safety boards
  11. Integrating AI risk into enterprise risk management
  12. Benchmarking risk posture against industry peers
Module 5. Data Integrity and Provenance in AI Systems
Ensure ALCOA+ principles are maintained when training and deploying AI models.
12 chapters in this module
  1. Applying ALCOA+ to AI training and validation data
  2. Designing data lineage pipelines for model inputs
  3. Validating data transformation steps in AI workflows
  4. Controlling access and modification rights in AI datasets
  5. Auditing data usage across distributed research teams
  6. Handling sensitive patient and genomic data responsibly
  7. Ensuring data consistency across hybrid cloud environments
  8. Documenting data decisions for regulatory inspection
  9. Managing synthetic data and augmentation techniques
  10. Verifying data quality before model deployment
  11. Establishing data governance councils for AI
  12. Reconciling data policies across international sites
Module 6. Model Development Lifecycle in Regulated Settings
Follow a structured, auditable process from concept to deployment.
12 chapters in this module
  1. Defining use cases with regulatory and clinical relevance
  2. Conducting feasibility studies for AI in R&D
  3. Selecting appropriate algorithms for biological data
  4. Building validation datasets with scientific rigor
  5. Documenting model development decisions comprehensively
  6. Implementing version control for code and models
  7. Creating model cards and technical specifications
  8. Integrating peer review into development cycles
  9. Preparing for independent model validation
  10. Establishing reproducibility standards
  11. Managing dependencies and software supply chain
  12. Transitioning from prototype to production
Module 7. Validation and Verification of AI Models
Execute scientifically sound and auditable validation processes.
12 chapters in this module
  1. Designing validation strategies for AI in drug discovery
  2. Defining performance metrics acceptable to regulators
  3. Conducting out-of-sample and external validation
  4. Assessing model generalizability across populations
  5. Using statistical methods to confirm robustness
  6. Documenting validation results for audit readiness
  7. Engaging third-party validators effectively
  8. Handling failed validation attempts transparently
  9. Revalidating after model updates or data shifts
  10. Linking validation outcomes to risk classification
  11. Balancing speed and thoroughness in validation
  12. Creating reusable validation templates
Module 8. AI in Discovery and Preclinical Research
Deploy AI to accelerate target identification, compound screening, and toxicity prediction.
12 chapters in this module
  1. Using AI for target validation and pathway analysis
  2. Predicting binding affinity and selectivity with machine learning
  3. Optimizing high-throughput screening workflows
  4. Reducing false positives in hit identification
  5. Predicting ADMET properties early in development
  6. Enhancing organoid and in vitro model interpretation
  7. Integrating multi-omics data with AI models
  8. Supporting IND-enabling studies with AI insights
  9. Documenting AI contributions to preclinical packages
  10. Collaborating with CROs on AI-augmented studies
  11. Managing intellectual property in AI-generated discoveries
  12. Communicating AI value to discovery leadership
Module 9. AI in Clinical Trial Design and Execution
Improve trial efficiency, site selection, and patient recruitment using AI.
12 chapters in this module
  1. Optimizing trial design with predictive enrollment modeling
  2. Using AI to identify high-performing clinical sites
  3. Predicting protocol deviations and operational risks
  4. Enhancing patient stratification and biomarker selection
  5. Supporting adaptive trial designs with real-time analytics
  6. Improving informed consent comprehension with NLP
  7. Monitoring safety signals with AI-driven pharmacovigilance
  8. Integrating wearable and digital biomarker data
  9. Ensuring data privacy in decentralized trials
  10. Documenting AI use in clinical study reports
  11. Engaging IRBs and ethics committees on AI tools
  12. Demonstrating operational ROI of AI in trials
Module 10. Change Management and Organizational Adoption
Drive acceptance of AI tools across scientific, regulatory, and operational teams.
12 chapters in this module
  1. Assessing organizational readiness for AI transformation
  2. Building cross-functional AI champions
  3. Addressing scientist skepticism with evidence-based pilots
  4. Designing training programs for non-technical users
  5. Communicating wins and learning from failures
  6. Integrating AI into standard operating procedures
  7. Updating job descriptions and performance goals
  8. Managing resistance from legacy system owners
  9. Scaling successful pilots across therapeutic areas
  10. Creating feedback loops for continuous improvement
  11. Celebrating milestones to sustain momentum
  12. Measuring cultural adoption over time
Module 11. AI Communication for Executive and Regulatory Audiences
Translate technical details into clear, actionable insights for decision-makers.
12 chapters in this module
  1. Crafting executive summaries of AI initiatives
  2. Visualizing model performance for non-experts
  3. Explaining uncertainty and limitations transparently
  4. Preparing for board Q&A on AI risks and benefits
  5. Responding to regulator inquiries about AI systems
  6. Using storytelling to convey AI impact
  7. Avoiding overstatement and hype in communications
  8. Tailoring messages to different stakeholder groups
  9. Building credibility through consistency and clarity
  10. Documenting communication strategies for audits
  11. Managing external messaging and press inquiries
  12. Establishing communication protocols for incidents
Module 12. Sustaining AI Excellence in R&D Operations
Maintain high performance, compliance, and innovation capacity over time.
12 chapters in this module
  1. Establishing continuous monitoring for deployed models
  2. Planning for model retraining and lifecycle management
  3. Updating governance as AI capabilities evolve
  4. Investing in talent development and upskilling
  5. Benchmarking against industry best practices
  6. Conducting post-implementation reviews
  7. Refining ROI measurement for AI initiatives
  8. Integrating lessons learned into future projects
  9. Supporting innovation while maintaining control
  10. Aligning AI strategy with long-term portfolio goals
  11. Engaging with external consortia and standards bodies
  12. Preparing for next-generation AI technologies

How this maps to your situation

  • You're leading an AI initiative in drug development and need board alignment
  • You're building a governance framework for AI in a regulated environment
  • You're preparing for regulatory inspection of AI-augmented processes
  • You're scaling AI from pilot to enterprise-wide deployment in R&D

Before vs. after

Before
Unclear governance, inconsistent documentation, and misaligned stakeholder expectations slow AI adoption and increase compliance risk.
After
Structured frameworks, board-ready communication, and audit-compliant processes enable confident, scalable AI integration across R&D.

What's included with your purchase

  • 12 modules with 12 chapters each (144 chapters)
  • Downloadable templates and worked examples for every module
  • Hand-built implementation playbook delivered alongside course access
  • 30-day money-back guarantee

Delivery and format

  • Course and learning environment access provisioned within 24 hours of purchase
  • Hand-built implementation playbook delivered alongside course access

Format: Text-based modules and chapters in the Art of Service learning environment, plus downloadable templates and worked examples for every chapter, plus the hand-built implementation playbook delivered alongside course access.

Time investment: Approximately 60, 70 hours of self-paced learning, designed for busy professionals balancing operational responsibilities.

If nothing changes
Without structured governance and implementation clarity, AI initiatives risk rejection by oversight bodies, regulatory scrutiny, or operational failure, delaying innovation and eroding stakeholder trust.

How this compares to the alternatives

Unlike generic AI courses or academic programs, this offering is tailored specifically to pharmaceutical R&D in regulated environments, with implementation-grade tools, real-world templates, and strategic guidance for executive engagement.

Frequently asked

Who is this course designed for?
It's designed for business and technology leaders in pharma and life sciences who are guiding AI adoption in R&D under regulatory oversight.
How is the course structured?
12 modules, each containing 12 chapters (144 chapters total).
Is prior AI experience required?
Familiarity with R&D processes is essential; technical AI knowledge is helpful but not required, the course builds practical understanding from the ground up.
$199 one-time. Approximately 60, 70 hours of self-paced learning, designed for busy professionals balancing operational responsibilities..

Within 24 hours your account in the learning environment is provisioned and the tailored implementation playbook is delivered alongside it.

30-day money-back guarantee· 144 chapters· Hand-built playbook included· Account access within 24 hours
!